Document Detail


Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: Focus on cerebral amino acid influx.
MedLine Citation:
PMID:  21820344     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Striatal degeneration from glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type 1, GA1) is associated with cerebral formation and entrapment of glutaryl-CoA and its derivatives that depend on cerebral lysine influx. In 2006 we designed a lysine-free study formula enriched with arginine to selectively block lysine transport across cerebral endothelia and thereby limit glutaryl-CoA production by brain. Between 2006 and present, we treated twelve consecutive children with study formula (LYSx group) while holding all other treatment practices constant. Clinical and biochemical outcomes were compared to 25 GA1 patients (PROx group) treated between 1995 and 2005 with natural protein restriction (dietary lysine/arginine ratio of 1.7±0.3mg:mg). We used published kinetic parameters of the y+and LAT1 blood-brain barrier transporters to model the influx of amino acids into the brain. Arginine fortification to achieve a mean dietary lysine/arginine ratio of 0.7±0.2mg:mg was neuroprotective. All 12 LYSx patients are physically and neurologically healthy after 28 aggregate patient-years of follow up (current ages 28±21months) and there were no adverse events related to formula use. This represents a 36% reduction of neurological risk (95% confidence interval 14-52%, p=0.018) that we can directly attribute to altered amino acid intake. During the first year of life, 20% lower lysine intake and two-fold higher arginine intake by LYSx patients were associated with 50% lower plasma lysine, 3-fold lower plasma lysine/arginine concentration ratio, 42% lower mean calculated cerebral lysine influx, 54% higher calculated cerebral arginine influx, 15-26% higher calculated cerebral influx of several anaplerotic precursors (isoleucine, threonine, methionine, and leucine), 50% less 3-hydroxyglutarate excretion, and a 3-fold lower hospitalization rate (0.8 versus 2.3 hospitalizations per patient per year). The relationship between arginine fortification and plasma lysine indicates that transport competition exists at both cerebrovascular and gastrointestinal barriers, suggesting their co-administration is key to efficacy. Monitoring the ratio between lysine and arginine in diet and plasma may prove a useful strategy for treating children with GA1.
Authors:
Kevin A Strauss; Joan Brumbaugh; Alana Duffy; Bridget Wardley; Donna Robinson; Christine Hendrickson; Silvia Tortorelli; Ann B Moser; Erik G Puffenberger; Nicholas L Rider; D Holmes Morton
Related Documents :
20725554 - Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, an...
2418204 - Antibodies to ribonucleic acids detected by elisa in systemic lupus erythematosus, syst...
12749824 - The effects of tannic acid on cytochrome p450 and phase ii enzymes in mouse liver and k...
22155164 - Arachidonic acid inhibits na(+)-k(+)-atpase via cytochrome p-450, lipooxygenase and pro...
2181454 - Effect of escherichia coli endotoxin on ascorbic acid transport in isolated adrenocorti...
10606524 - Nucleotide determinants for trna-dependent amino acid discrimination by a class i trna ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-12
Journal Detail:
Title:  Molecular genetics and metabolism     Volume:  -     ISSN:  1096-7206     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-8-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9805456     Medline TA:  Mol Genet Metab     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Clinic for Special Children, Strasburg, PA, USA; Department of Biology, Franklin and Marshall College, Lancaster, PA, USA; Lancaster General Hospital, Lancaster, PA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Attenuation of IGF-I receptor signaling inhibits serum-induced proliferation of prostate cancer cell...
Next Document:  Painful diabetic neuropathy: Diagnosis and management.